23rd Oct 2015 06:38
LONDON (Alliance News) - Cyprotex PLC on Friday said trading has been ahead of its expectations in the first nine months of 2015, and it anticipates its results for the year will exceed the current market view.
Cyprotex is a preclinical discovery and development contract research organisation working in the pharmaceutical, chemical, personal care and cosmetic industries.
The firm said its financial performance in the first nine months of 2015 has outpaced its own expectations, driven by a strong performance in the UK, though challenges have remained for its US operations.
Still, the US operations have improved year-on-year, and it now foresees both its overall revenue and earnings before interest, taxation, depreciation and amortisation for 2015 will be ahead of market expectations.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CRX.L